Skip to main content
Not investment advice. Educational platform. See Disclaimer.
NASDAQ: IMA

ImageneBio Inc

Healthcare | Biotechnology

No licensed closing price on file for IMA. This page shows the company’s SEC filings and filed figures, without a price or any ratio that depends on one.

ImageneBio Inc (NASDAQ: IMA) is a biotechnology company. Figures from SEC EDGAR; updated 2026-10-20 05:08 UTC.

Key facts

Valuation
Return on equity-34.06%

Revenue, margins & earnings

FY2021: net loss $34M on revenue $31M$31MFY2021FY2022: net loss $69M on revenue $16M$16MFY2022FY2023: net loss $68M on revenue $9M$9MFY2023FY2024: net loss $37M on revenue $4M$4MFY2024FY2025: net loss $45M on revenue $800,000$800,000FY2025
  • Net income
  • Taxes & interest
  • Operating costs
  • Net loss year
Annual revenue; bands show net, operating margins · Open in Platform →

SEC Filings

SEC EDGAR ↗
Recent Insider Activity (last 90 days)
Source: SEC EDGAR · Filed 2026-08-17
  • 2026-08-17Chief Financial OfficerAward39,000—
  • 2026-08-17Chief Financial OfficerAward65,000—
  • 2026-08-17Chief Executive OfficerEmployee Stock Option (Right to Buy)Award250,000—
Sign in to see all transactions →
Recent 8-K Events (parsed from SEC filings)All events →
Source: SEC EDGAR 8-K filings · Interpretation: Oxford Ledge parser · Confidence-filtered ≥ 0.50

Company news

View all →
No qualifying company news in the archive. Full tape in the platform →

Questions this page answers

What does ImageneBio Inc do?

ImageneBio Inc is a biotechnology company, listed on NASDAQ as IMA.

When did IMA last file with the SEC?

ImageneBio Inc's most recent SEC filing on record is a 8-K filed 2026-06-26. All filings link to their SEC EDGAR originals above.

Where does this data come from?

SEC EDGAR filings, with the company profile (sector, industry, exchange) from public data providers, fetched 2026-10-20 05:08 UTC. This page is also available as JSON at /api/data?ticker=IMA and is emitted with FAQPage structured data for machine reading.

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for IMA and 5,000+ tickers.

Create a free account — keep IMA
For your agent
GET /api/data?ticker=IMA

This page as JSON via rel="alternate" · REST API docs · MCP server (60 tools) · llms.txt